Stay updated on GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1. No changes to study content or data are visible.
    Difference
    0.1%
    Check dated 2026-02-04T23:42:47.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Show glossary was added, and metadata labels were updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data) with the revision/version updated to v3.4.0, replacing the previous v3.3.4 label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T20:28:14.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision was updated to v3.3.4, representing a minor metadata update that does not affect the study information shown. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:01:38.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Locations now includes New York; HHS Vulnerability Disclosure and New York Locations were removed. Page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:22:42.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:25:38.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Removed an administrative notice about government funding and NIH operating status from the study page. This is an operational change and does not affect the study details, eligibility criteria, or results planning.
    Difference
    0.4%
    Check dated 2025-11-17T19:13:25.000Z thumbnail image

Stay in the know with updates to GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.